3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
CNS
2
Tumor-Agnostic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Sarcoma
1
Interventions
Specimen Handling
36
Magnetic Resonance Spectroscopy
31
Cyclophosphamide
28
Doxorubicin
23
Biopsy
22
pembrolizumab
21
Temozolomide
21
X-Rays
17
Radiotherapy
17
Radiation
16
Nivolumab
13
fludarabine
12
atezolizumab
12
Vincristine
12
Phantoms, Imaging
12
Irinotecan
12
Ifosfamide
12
Gemcitabine
12
cabozantinib
10
Bevacizumab
9
liposomal doxorubicin
8
Surgical Procedures, Operative
8
Paclitaxel
8
Ipilimumab
8
Etoposide
8
Immunoglobulin G
7
Carboplatin
7
palbociclib
6
olaparib
6
fludarabine phosphate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Protons
×
Sarcoma
×
90 days
×
Clear all
NCT04946357
2026-04-06
EXTREM ION
University Hospital Heidelberg
Phase NA
Recruiting
42 enrolled